I G Homoeo Remedies Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 23-10-2024
- Paid Up Capital ₹ 0.20 M
as on 23-10-2024
- Company Age 20 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 6.90 M
as on 23-10-2024
- Revenue 0.10%
(FY 2023)
- Profit -14.82%
(FY 2023)
- Ebitda -8.43%
(FY 2023)
- Net Worth 6.34%
(FY 2023)
- Total Assets 17.70%
(FY 2023)
About I G Homoeo Remedies
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.20 M.
The company currently has active open charges totaling ₹6.90 M.
Zubin Thomas and Nitin Thomas serve as directors at the Company.
- CIN/LLPIN
U24234DL2004PTC131039
- Company No.
131039
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 Dec 2004
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does I G Homoeo Remedies Private Limited offer?
I G Homoeo Remedies Private Limited offers a wide range of products and services, including Anti Infective Drugs & Medicines, Antibacterial Drugs, Homeopathic Medicines & Remedies, Homeopathic Drugs.
Who are the key members and board of directors at I G Homoeo Remedies?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nitin Thomas  | Managing Director | 24-Aug-2016 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Zubin Thomas | Whole-Time Director | 01-Apr-2009 | Current |
Financial Performance of I G Homoeo Remedies.
I G Homoeo Remedies Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 0.1% increase. The company also saw a substantial fall in profitability, with a 14.82% decrease in profit. The company's net worth moved up by a moderate rise of 6.34%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of I G Homoeo Remedies?
In 2023, I G Homoeo Remedies had a promoter holding of 83.50% and a public holding of 16.50%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 01 Nov 2022 | ₹2.00 M | Open |
The South Indian Bank Limited Creation Date: 24 Aug 2007 | ₹2.50 M | Open |
The South Indian Bank Ltd. Creation Date: 08 Oct 2005 | ₹2.40 M | Open |
How Many Employees Work at I G Homoeo Remedies?
I G Homoeo Remedies has a workforce of 69 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of I G Homoeo Remedies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped I G Homoeo Remedies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
